Heparin suppresses lipopolysaccharide-induced monocyte production of several cytokines, but simultaneously stimulates C3 production
- 15 October 1995
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 80 (2) , 179-184
- https://doi.org/10.1016/0049-3848(95)00164-m
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Transforming growth factor β modulates C3 and factor B biosynthesis and complement receptor 3 expression in cultured human monocytesJournal of Leukocyte Biology, 1995
- Heparin oligosaccharides bind L- and P-selectin and inhibit acute inflammationBlood, 1993
- Identification of multiple sites of interaction between heparin and the complement systemMolecular Immunology, 1993
- Heparin, Polycations, and AtherosclerosisSeminars in Thrombosis and Hemostasis, 1993
- FcgammaR-Dependent Regulation of the Biosynthesis of Complement C3 by Murine Macrophages: the Modulatory Effect of IL-6Scandinavian Journal of Immunology, 1992
- Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processesPhysiological Reviews, 1991
- Heparin stimulates the synthesis and modifies the sulfation pattern of heparan sulfate proteoglycan from endothelial cellsJournal of Cellular Physiology, 1989
- Heparin binds to human monocytes and modulates their procoagulant activities and secretory phenotypes. Effects of histidine-rich glycoproteinBlood, 1989
- Interleukin 6, the third mediator of acute‐phase reaction, modulates hepatic protein synthesis in human and mouse. Comparison with interleukin 1 β and tumor necrosis factor‐αEuropean Journal of Immunology, 1988
- Rheumatoid ArthritisNew England Journal of Medicine, 1974